• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gennex Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Prudential
  • BSE Code : 14707.0
  • ISIN : INE509C01026
13.90 0 (0.80%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    13.00

  • Today’s High

    14.00

  • Open

    13.78

  • Perv Close

    13.79

  • 52W Low

    11.15

  • 52W High

    29.00

Key Indicators

  • P/E(TTM)

    19.31

  • Mar.Cap (₹Cr.)

    316.15

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.62

  • Debt-Equity Ratio

    0.80

  • AGM Date

    30-May-2025

  • EPS

    0.72

  • P/E Ratio

    19.31

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    316.15

  • RONW (%)

    10.51

  • ROCE (%)

    13.64

Score Board

  • Equity (₹ in Cr.)

    22.74

  • BV (₹)

    7.60

  • Sales( ₹ in Cr.)

    66.80

  • NP (in Cr.)

    11.80

  • NP Var(%)

    161.0

  • Div%

    0.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    316.15

  • 52 Week High

    29.00

  • 52 Week Low

    11.15

  • Price BSE

    14.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    316.15

  • P/C Ratio

    25.30

  • P/E Ratio

    27.00

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 74.05 71.35 65.26 63.65 59.96 59.96
Excise Duty 7.25 6.25 4.05 4.00 4.34 4.16
Net Sales 66.80 65.10 61.21 59.65 55.62 55.80
Other Income 4.30 3.40 1.38 0.52 1.06 0.78
Stock Adjustments 2.44 7.00 1.91 -1.53 1.51 2.39
Total Income 73.54 75.50 64.50 58.64 58.19 58.97
EXPENDITURE :            
Raw Materials 41.94 48.14 41.23 35.18 36.20 36.31
Power and Fuel Cost 3.29 4.26 3.17 3.01 3.30 2.85
Employee Cost 6.05 7.71 6.97 7.21 6.81 6.12
Other Manufacturing Expenses 1.06 1.18 0.80 2.14 3.67 3.97
Selling and Administration Expenses 2.93 4.40 3.43 3.44 3.34 4.23
Miscellaneous Expenses 1.54 1.82 2.15 0.98 0.56 0.69
Employee Benefit Expenses 6.05 7.71 6.97 7.21 6.81 6.12
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 56.81 67.51 57.74 51.96 53.88 54.17
Operating Profit 16.73 7.99 6.76 6.68 4.30 4.80
Interest 1.16 1.23 0.88 0.74 0.75 0.79
Gross Profit 15.57 6.76 5.88 5.94 3.55 4.01
Depreciation 0.81 0.74 0.79 0.88 1.00 0.98
Profit Before Tax 14.76 6.02 5.09 5.06 2.55 3.03
Current Tax 3.05 1.59 1.32 1.27 0.85 0.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.09 -0.14 -0.15 -0.25 -0.16 -0.05
Reported Net Profit 11.80 4.56 3.92 4.04 1.86 2.22
Extraordinary Items 0.00 0.04 0.00 -0.28 0.08 0.00
Adjusted Net Profit 11.80 4.52 3.92 4.32 1.78 2.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 28.22 23.66 19.74 15.70 13.84 11.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 40.02 28.22 23.66 19.74 15.70 13.84
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.52 0.25 0.31 0.32 0.15 0.18
Earnings Per Share(Adj)-Unit Curr 0.52 0.25 0.30 0.31 0.14 0.17
Book Value 7.26 4.39 3.48 3.15 2.83 2.69
Book Value(Adj)-Unit Curr 7.26 4.39 3.32 3.00 2.69 2.57

Shareholding Pattern

  • Promoter Group

    18.42%

  • Public Share Holding

    81.58%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 41,071,874 18.06 41,071,874 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 48,300 0.02 48,300 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 765,450 0.34 765,450 1
Others 0 0.00 0 0
Sub Total 41,885,624 18.42 41,885,624 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 3,600 0.00 3,600 1
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,600 0.00 3,600 1
2] Non Institution
Bodies Corporate 28,821,095 12.67 28,819,095 265
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 8,523,373 3.75 8,523,373 796
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 37,375,572 16.43 37,375,572 68
Individuals holding nominal share capital up to Rs. 1 lakh 104,084,146 45.76 102,059,816 91,104
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 61,850 0.03 61,850 3
Others 0 0.00 0 0
Sub Total 185,558,450 81.58 183,532,120 92,316
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 227,447,674 100.00 225,421,344 92,326

Company Background

Gennex Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Gennex Laboratories Ltd
  • BSE Code : 14707.0
  • ISIN : INE509C01026

  • Incorporation Year

    1990

  • Registered Office

    Survey No 133 Bollaram
    Jinnaram Mandal, Medak,
    Telangana-502325

  • Telephone

    91-8458-279406/279516

  • FAX

  • Chairman

    Arihant Baid

  • Managing Director

    Arihant Baid

  • Company Secretary

    Dinesh Kumar Kejriwal.

  • Auditor

    R Pugalia & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    R & D Infotech Pvt Ltd
    7A Betala Road,
    1st Floor,
    Mumbai - Kolkata - 700 026

Gennex Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gennex Lab. 13.90 71.10 74.05 19.31 12.50
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92